HQL-79

• Description:

  HQL-79 is a selective and orally active human hematopoietic prostaglandin D synthase (H-PGDS) inhibitor. It inhibits the synthesis of PGD2 and acts as an anti-allergic agent (Kd: 0.8 μM and IC50: 6 μM) . It also shows no obvious effect on COX-1, COX-2, m-PGES, or L-PGDS.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  377.48

• Molecular Formula:

  C22H27N5O

• Notes:

  Research use only, not for human use.

• Receptor:

  Other Targets

• CAS Number:

  162641-16-9